While judging the Medicines and Healthcare products Regulatory Agency’s (MHRA) response to the PIP silicone breast implant scandal basically sound, a new review by the UK Department of Health (DOH) finds the agency needs better access to information on devices to preclude similar safety scares in the future.
Report: PIP Case Highlights MHRA’s Need for More, Better Medical Device Data
- Post author:Sam
- Post published:April 7, 2016
- Post category:International Medical Device Regulatory Monitor